Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Henderson

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 27, 2013
Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomesD K Woolf, M Williams, C L Goh, et al.
Cancer Research|February 24, 2001
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxelD C Yu, Y Chen, J Dilley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 2015
Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate RadiotherapyD R Henderson, J R Murray, A C Tree, et al.
Annals of the Rheumatic Diseases|November 1, 1974
Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary reportE C Huskisson, T J Gibson, H W Balme, et al.
Annals of the Rheumatic Diseases|July 1, 1974
Proceedings: Penicillamine or gold for rheumatoid arthritis? Multicentre trial using 'blind' observers. The first six monthsE C Huskisson, T J Gibson, H W Balme, et al.
Cancer Research|July 17, 2001
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicityY Chen, T DeWeese, J Dilley, et al.
Cancer Research|October 19, 2001
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapyT L DeWeese, H van der Poel, S Li, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 27, 2013
Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomesD K Woolf, M Williams, C L Goh, et al.
Cancer Research|February 24, 2001
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxelD C Yu, Y Chen, J Dilley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 2015
Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate RadiotherapyD R Henderson, J R Murray, A C Tree, et al.
Annals of the Rheumatic Diseases|November 1, 1974
Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary reportE C Huskisson, T J Gibson, H W Balme, et al.
Annals of the Rheumatic Diseases|July 1, 1974
Proceedings: Penicillamine or gold for rheumatoid arthritis? Multicentre trial using 'blind' observers. The first six monthsE C Huskisson, T J Gibson, H W Balme, et al.
Cancer Research|July 17, 2001
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicityY Chen, T DeWeese, J Dilley, et al.
Cancer Research|October 19, 2001
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapyT L DeWeese, H van der Poel, S Li, et al.
Pageof 5